Vitanova Life Sciences Corp

Vitanova maintains a strong liquidity position with $593,040 in cash and equivalents, representing 50% of total assets, and a current ratio of 8.71, significantly above the industry median. The company is debt-free, with no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative capital structure. Profitability metrics show a return on equity (ROE) of 15.9% and a return on assets (ROA) of 14.08%, both exceeding the industry median for Apparel & Accessories. Operating income of $232,680 and net income of $167,920 reflect strong margins, with a gross profit margin of 64.6%. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic or regulatory risks. Vitanova's revenue growth is expected to remain stable, with no significant changes projected in the current or next fiscal year. Historical revenue of $544,590 shows consistent performance, but no growth drivers are disclosed in the available data. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued additional shares in the past year, and no dilution sources were identified in the 10-K or other filings. Recent events include the filing of the latest financial statements, which show strong profitability and liquidity. No material events or earnings call transcripts were identified in the available data.